Physician profile
Todd R Otten
NPI 1710967930
$920.76
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $125 · 2021: $58.57 · 2022: $83.04 · 2023: $25.94 · 2024: $32.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $240.86 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $111.06 | 2019 | |
| Pfizer INC. | $72.01 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $57.91 | 2019 | |
| Lilly USA, LLC | $48.21 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $45.33 | 2019-2023 | Spravato |
| Astrazeneca Pharmaceuticals Lp | $41.20 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $36.34 | 2019 | |
| Glaxosmithkline, LLC. | $34.96 | 2020-2022 | |
| Phadia US INC. | $33.23 | 2021-2022 | |
| Abbvie INC. | $32.79 | 2024 | |
| Merck Sharp & Dohme LLC | $24.58 | 2019 | |
| Melinta Therapeutics, LLC | $21.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.40 | 2019 | |
| Astellas Pharma US INC | $16.61 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $14.93 | 2019 | |
| Allergan, INC. | $14.50 | 2019 | |
| Radius Health, INC. | $13.91 | 2019 | |
| Abbott Laboratories | $13.56 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.52 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Otten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.